Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FZ83Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,975
Award facts
- Contract value 100% obligated
- $7,975.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,975.00 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors under a firm fixed-price contract on December 1, 2025, with an ultimate completion date of December 2, 2025. This non-competitive delivery order is issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Repatha (evolocumab) is a PCSK9 inhibitor indicated for reducing cardiovascular risk in patients with elevated cholesterol levels, particularly those with familial hypercholesterolemia or established cardiovascular disease. This delivery order represents routine pharmaceutical supply replenishment under the broader DLA Troop Support Medical prime vendor vehicle, which consolidates the military's pharmaceutical procurement through a single distributor capable of managing global pharmaceutical logistics and supporting diverse therapeutic domains. The company's track record with the DLA includes delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DR26FZ83Q?
SPE2DR26FZ83Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FZ83Q worth?
The government has obligated $7,975 on SPE2DR26FZ83Q.
Is contract SPE2DR26FZ83Q an order under another contract?
Yes. SPE2DR26FZ83Q is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ83Q competed?
The extent of competition for SPE2DR26FZ83Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award